Cutler Group LP Neogenomics Inc Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$7.06 - $13.97 $17,494 - $34,617	2,478 New	2,478 $20,000
Q1 2022 Apr 14, 2022	SELL	$12.15 - $35.28 $7,290 - $21,168	-600 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$30.49 - $48.49 $15,245 - $24,245	-500 Reduced 45.45%	600 $20,000
Q3 2021 Oct 26, 2021	BUY	$41.66 - $52.52 $17,372 - $21,900	417 Added 61.05%	1,100 $53,000
Q4 2020 Jan 21, 2021	SELL	$36.08 - $56.47 $38,172 - $59,745	-1,058 Reduced 60.77%	683 $36,000
Q2 2020 Jul 22, 2020	BUY	$24.21 - $31.02 $29,052 - $37,224	1,200 Added 221.81%	1,741 $53,000
Q1 2020 May 07, 2020	BUY	$20.5 - $34.53 $6,150 - $10,359	300 Added 124.48%	541 $14,000
Q4 2019 Feb 06, 2020	BUY	$18.96 - $29.84 $4,569 - $7,191	241 New	241 $7,000
Q4 2017 Jan 17, 2018	SELL	$8.02 - $11.18 $4,010 - $5,590	-500 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$9.11 - $11.26 $4,555 - $5,630	500	500 $5,000

282

124M

751K

107K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.24B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.